• About us
• Contact

Advertisement

Organisation › Details

Keros Therapeutics Inc. (KROS)

Keros Therapeutics harnesses the knowledge of leading physician researchers and medical experts in the discovery and development of novel proprietary therapeutics for neuromuscular diseases. Headquartered in Lexington, Massachusetts, Keros Therapeutics is led by President and CEO Dr. Jasbir Seehra, who has over three decades of hands-on experience creating first-tier drug therapies. An expert in both biologic and small-molecule drug development, Dr. Seehra leads the Keros team as it explores approaches to treating some of the most intractable neuromuscular diseases, such as fibrodysplasia ossificans progressiva (FOP). The innovative work Keros Therapeutics is pursuing could bring relief to those who suffer from rare and ultra-rare neuromuscular diseases. *

 

	Start	2016-04-01 existent
	Industry	pharmaceutical
	Industry 2	drug development
	Person	Seehra, Jasbir (Keros Therapeutics 201901 CEO)
	Region	Lexington, MA
	Country	United States (USA)
	Street	99 Hayden Avenue Suite 120 (Building E)
	City	02421 Lexington, MA
	Tel	+1-617-314-6297
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA.
		Record changed: 2023-07-10

Advertisement

More documents for Keros Therapeutics Inc. (KROS)

• [1] Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.